Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review claims


     Quick Explanation



    Author review — Masayori Inouye (concise)

    The supplied author record shows a small publication set (3 papers), h-index = 2 and total citations = 15 (user-supplied metadata). That profile implies limited citation impact to date and requires cautious interpretation — small-n outputs can still contain high-quality work, but the bibliometric footprint is small. Two high-quality field papers in the provided dataset (Cell 1987 and PNAS 2000) illustrate the kinds of rigorous, experimental work used for comparison below.

    Representative rigorous studies in the dataset used to contextualize molecular microbiology expertise:
    - Structure of msDNA from Myxococcus xanthus (Cell 1987) — detailed molecular mapping and a strong mechanistic proposal for msDNA synthesis by a branched RNA precursor.
    - EnvZ phosphatase domain analysis (PNAS 2000) — biochemical dissection of histidine kinase phosphatase activity with clear in vitro/in vivo assays.

    Short takeaway: the author’s bibliometric metrics are low (3 papers, h-index 2, 15 citations) which limits claims of broad influence; however, the field-level literature cited here contains several high-quality mechanistic experiments worth emulating for rigor and reproducibility.

    Selected supporting sources (examples from dataset):




     Long Explanation



    Author Review — Masayori Inouye (detailed, visual)

    Visual summary: bibliometrics (user-supplied)

    Note: the metrics plotted above are the author metadata you provided (h-index = 2; total citations = 15; paper count = 3). Bibliometric measures are blunt instruments — they do not replace careful reading of experimental methods, sample sizes, reproducibility, or domain impact.

    Evidence / context from high-quality papers in the dataset

    msDNA and retron biology (deep mechanistic work): The Cell 1987 study provides rigorous mapping of msDNA and its branched RNA in Myxococcus xanthus, using pulse-chase experiments, RNase mapping, enzymatic debranching and sequencing to define mature msDNA (162 nt) and msdRNA (77 nt) and to propose a self-priming reverse-transcription-like model for msDNA synthesis; that work is methodologically deep and mechanistic, and serves as an example of strong experimental evidence in this subfield

    Two-component kinase/phosphatase dissection (example of clear biochemical-genetic linkage): The PNAS 2000 paper shows how biochemical assays (purified domains, metal-dependence, ADP modulation) combined with in vivo reporters and targeted mutagenesis (His-243, L288P) yield a coherent mechanistic model — a strong example of using orthogonal evidence to strengthen causal claims about protein regulation

    Reverse transcriptase in bacteria — broader field relevance: A later Gene (2017) review/analysis in the dataset provides context that reverse transcriptase-like activities (retrons) occur in bacteria and reframes msDNA/retron work as relevant to a wider evolutionary and functional question, underscoring the field’s novelty and historical evolution

    Critical assessment of the author's scientific strength

    1. Bibliometrics indicate low current impact: h-index = 2, total citations = 15, paper count = 3 (user-provided) — these are low values, implying limited cumulative influence in the literature so far; small sample sizes in bibliometrics increase uncertainty and sensitivity to single-outcome effects.
    2. Methodological depth (uncertain): The dataset contains exemplar high-rigor papers in the field (Cell 1987 and PNAS 2000) — these demonstrate the type of experimental completeness one should expect for strong mechanistic claims (multiple orthogonal assays, clear mutants, biochemical reconstitution). It is not possible from the supplied author metadata alone to confirm that all of the author’s papers reach that level of methodological depth.
    3. Reproducibility and data availability: Several dataset papers explicitly list limitations (e.g., reliance on gel-based inference, absence of deposited raw datasets). For an author with few papers, transparent raw-data deposition, detailed methods, and independent replication are especially important to cement claims.
    4. Novelty vs. community uptake: Novel mechanistic proposals (e.g., self-priming msDNA synthesis) are high-value but require independent corroboration; novelty alone without follow-up citations or replication limits community acceptance (and thus citation accumulation).
    5. Potential blindspots and biases to watch for: small author publication sets amplify risks from publication bias, selective reporting, or unintentional overinterpretation of limited data; confirmatory orthogonal experiments (genetics + biochemistry + in vivo complementation) reduce these risks.

    How to falsify/robustly test the main molecular claims in similar works: use independent genetic disruption (deleting retron RT / branch-point G), biochemical reconstitution of RT-dependent DNA synthesis, in vivo complementation assays, and high-resolution sequencing of msDNA species; absence of msDNA under those perturbations would falsify a self-priming retron model (this mirrors falsification paths highlighted in the Cell 1987 paper).

    Practical recommendations (for author or evaluators)

    • Deposit raw sequencing/gels and protocols in public repositories and include accession numbers in future manuscripts to increase reproducibility and citations.
    • Design orthogonal experiments (genetics + purified biochemistry + in vivo assays) to strengthen causal inference and reduce alternative explanations.
    • Conduct and publish replication/extension studies or collaborate with independent labs to validate unusual mechanistic claims (this increases credibility and bibliometric impact).
    • Provide clearer statements of limitations and potential confounders in methods/results (improves scientific rigor and trustworthiness).

    Final, evidence-based conclusion

    Based on the small bibliometric footprint (3 papers; h-index 2; 15 citations) and the high-quality examples in the dataset used as contextual anchors (Cell 1987; PNAS 2000), the author’s current scientific strength appears to be limited in terms of field-wide impact but cannot be judged solely by metrics — direct evaluation of the author’s experimental rigor, data availability, and orthogonal evidence in their specific papers is needed to give a final verdict. To change this conclusion, one would need transparent raw data, independent replication of key findings, or follow-up studies showing broader uptake and validation.

    Important caveat: this review uses the exact author metadata you supplied plus a small set of dataset papers for context; if you want a deeper, paper-by-paper critique (methods-level), run the AI Scientist Analysis above to fetch full texts, extract methods, and generate reproducibility & risk-of-bias scores.

    Selected dataset references used in evaluation (examples):




    Feedback:    

    Updated: March 17, 2026

     BGPT Author Review



    Scientific Quality

    30%

    Low bibliometric footprint (3 papers, h-index 2, 15 citations) limits evidence of sustained community impact; possible isolated technical competence but insufficient published/replicated output to demonstrate broad scientific strength.



    Communication Quality

    60%

    Unknown from metadata alone; available dataset examples show clear reporting and method-level detail typical of high-quality molecular papers, suggesting communication can be good if similar style is followed; cannot confirm across all author papers.



    Author Novelty

    60%

    Work touches on mechanistically novel topics (retron/msDNA biology) that are inherently novel in the field; novelty is present but not yet broadly propagated or validated by independent citations.



    Scientific Rigor

    50%

    Rigor cannot be fully assessed without paper-level method review and raw data; the field examples demonstrate high rigor standards — the author must match those (orthogonal assays, mutants, raw data) to score higher; current metadata provides insufficient evidence.

     Top Data Sources ExportMCP



     Analysis Wizard



    Parsing provided paper metadata to compute per-decade publication counts, basic bibliometrics, and plot time-distribution; useful for visualizing author output and dataset context.



     Hypothesis Graveyard



    All msDNA-like molecules arise from host contamination — unlikely given targeted genetic maps and enzymatic debranching evidence reported in Cell 1987.


    Retrons are purely selfish elements with no host function — field evidence shows conserved structures and regulated expression suggesting possible functional roles, so this strong claim lacks support.

     Science Art


    Author Review: Masayori Inouye Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT